About Melanoma
About Melanoma
Overview
Learn about all things melanoma — prevention, types, stages, and more.
Melanoma 101
Get answers to the most common FAQ about the deadliest form of skin cancer.
Types of Melanoma
Educate yourself on cutaneous, acral, mucosal, and uveal melanoma.
Early Detection
Know what to look for to identify melanoma earlier.
Melanoma Staging
Determine your prognosis and identify the best treatment plan for you.
Prevention
Understand your risk for melanoma and ways to practice prevention.
Melanoma & Skin of Color
Learn more about the risks of melanoma among people of color.
For Patients
For Patients
Patient Overview
Learn about available resources, from treatment options to clinical trials and more.
Just Diagnosed
Ten things you can do to get up to speed as you start your melanoma journey.
Screening & Diagnosis
Learn more about screenings, biopsies, biomarkers, and more.
Case Studies
Explore insights on innovative treatment approaches and emerging research.
Treatment Options
Understand the various treatment options available for melanoma.
Clinical Trials
Your treatment approach is a big decision. See if clinical trials are a potential option for you.
Patient Resources
Our patient support community, patient assistance programs, travel support, and more.
Research
Research
Research Overview
See MRA's impact as the world's largest nonprofit funder of melanoma research.
Priority Areas
MRA funds research across the melanoma spectrum. Learn more about our priority areas.
MRA Grant Awards
Explore MRA's vast research portfolio.
Funding Opportunities
Throughout the year, we invite the research community to apply for funding.
Scientific Retreat
Read our most recent Retreat Report, explore sponsorship opportunities, and more.
RARE Registry
Join a groundbreaking research effort led by patients to advance melanoma research.
Researcher Resources
MRA has developed numerous resources to support researchers.
News
News
Blog
Read patient stories, research updates, and the latest news in melanoma.
Email Newsletters
Sign up to receive regular updates from the Melanoma Research Alliance.
Media
See past press releases and contact our Communications & Engagement team.
Patient Webinars
Connect with the melanoma community, learn about important topics, share insights and experiences, and ask questions.
Annual Progress Reports
Learn about our latest initiatives and achievements.
Get Involved
Get Involved
Donate
Ways You Can Help
Honor a Loved One
Start a Fundraiser
Clinical Trials
Events
Sponsor a Research Grant
Corporate Partnerships
Workplace Giving
Planned Giving
About MRA
About MRA
MRA Overview & Mission
Our mission is to end suffering and death due to melanoma by collaborating with many stakeholders to accelerate powerful research.
Board of Directors
Meet MRA's distinguished board members, who govern and advise MRA's endeavors.
Leadership Council
MRA's council members are committed to research, patient engagement, and advocacy.
Our Team
Meet the members of our dedicated and passionate team.
Advisory Boards
Our Grant Review Committee, Dermatology Council, Scientific Advisory Panel, and Medical Advisory Panel.
Financials
See why MRA is considered a highly effective charity that exceeds industry standards.
Careers
Explore opportunities to join Team MRA.
Donate
For Patients
>
Treatment Options
>
Quick Links
Learn more about your treatment options
Surgery
•
Complete Lymph Node Dissection for Melanoma
•
Mohs Surgery for Melanoma
•
Sentinel Lymph Node Biopsy in Melanoma
•
Wide Local Excision for Melanoma
Immunotherapy
•
Interleukin-2 (IL-2, Aldesleukin, PROLEUKIN®)
•
KIMMTRAK® (Tebentafusp)
•
Keytruda® (Pembrolizumab)
•
Nivolumab (Opdivo®) + Ipilimumab (Yervoy®)
•
Opdivo® (Nivolumab)
•
Opdualag™ (Nivolumab + Relatlimab)
•
T-VEC (Imlygic™)
•
Yervoy® (Ipilimumab)
Targeted Therapy
•
Dabrafenib (Tafinlar®)
•
Dabrafenib (Tafinlar®) + Trametinib (Mekinist®)
•
Encorafenib (Braftovi™) + Binimetinib (Mektovi®)
•
Trametinib (Mekinist®)
•
Vemurafenib (Zelboraf®)
•
Vemurafenib (Zelboraf®) + Cobimetinib (Cotellic™)
Chemotherapy
•
Liver-Directed Melphalan (Hepzato Kit)
Adjuvant Therapy
•
Dabrafenib (Tafinlar®) + Trametinib (Mekinist®) Adjuvant Therapy
•
Interferon (Intron® A or Sylatron™)
•
Ipilimumab Adjuvant Therapy
•
Nivolumab (Opdivo®) Adjuvant Therapy
•
Pembrolizumab (Keytruda®) Adjuvant Therapy
Cellular Therapy
•
Lifileucel (AMTAGVI)
Back to Treatment Options
Related Content
Targeted Therapy
Chemotherapy
Adjuvant Therapy
MRA’s newsletter
Share on social
